Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Simon Kallee"'
Autor:
Uwe Liebchen, Hanna Salletmeier, Simon Kallee, Christina Scharf, Lucas Huebner, Alexandra Weber, Michael Zoller
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Abstract The aim of this study was to investigate optimal loading doses prior to continuous infusion of meropenem in critically ill patients. A previously published and successfully evaluated pharmacokinetic model of critically ill patients was used
Externí odkaz:
https://doaj.org/article/35be4501d4fa47959d11c96691e45305
Autor:
Simon Kallee, Christina Scharf, Lea Marie Schatz, Michael Paal, Michael Vogeser, Michael Irlbeck, Johannes Zander, Michael Zoller, Uwe Liebchen
Publikováno v:
Pharmaceutics, Vol 14, Iss 9, p 1920 (2022)
Voriconazole (VRC) is used as first line antifungal agent against invasive aspergillosis. Model-based approaches might optimize VRC therapy. This study aimed to investigate the predictive performance of pharmacokinetic models of VRC without pharmacog
Externí odkaz:
https://doaj.org/article/16ad7566d2964aeb886c5e07021f2f4b
Autor:
Michael, Zoller, Michael, Paal, Antonia, Greimel, Simon, Kallee, Michael, Vogeser, Michael, Irlbeck, Ines, Schroeder, Uwe, Liebchen, Christina, Scharf
Publikováno v:
Journal of critical care. 71
The concentration-time profile of linezolid varies considerably in critically ill patients. Question of interest is, if the site of infection influences linezolid serum concentrations.68 critically ill patients, treated with linezolid, were included.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d180fa5fef3de1050d84ac9c82719fbc
https://pubmed.ncbi.nlm.nih.gov/36241467
https://pubmed.ncbi.nlm.nih.gov/36241467
Autor:
Michael Vogeser, Michael Zoller, Ines Schroeder, Michael Irlbeck, Nikolaus Kneidinger, Christina Scharf, Jette Jung, Michael Paal, Uwe Liebchen, Sebastian Michel, Johannes Zander, Christian Schneider, Simon Kallee
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation SocietyREFERENCES. 23(4)
BACKGROUND Posaconazole and itraconazole are commonly used for systemic antifungal prophylaxis after lung transplantation. The aim of this study on critically ill lung transplant recipients was to assess the rate of adequate plasma concentrations and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e46d5d058600b5e6c8eedaefc38f4a64
https://pubmed.ncbi.nlm.nih.gov/34166573
https://pubmed.ncbi.nlm.nih.gov/34166573